In an article published last week in Nature the extraordinary results of a research conducted by two different laboratories.
A mixture of HIV type 1 monoclonal antibodies is capable of eliminating the AIDS virus from the bodies of primates in just 3 days without leaving a trace.
The protagonist of the undertaking is the N332-glycan-dependent monoclonal antibody PGT121 mAb which is the main proponent of a very rapid decay of virus levels even in long-infected primates.
It is not yet a real "vaccine" in the true sense of the term, because the virus tends to recur in a time interval between 56 and 250 days, and an in-depth phase of testing is needed on primates not already infected, to understand whether administering it to a healthy organism prevents contagion.
The research, conducted by 2 different working groups (one at Harvard Medical School and one at the National Institute of Allergy and Infectious Diseases) could lead to a very powerful drug that makes you totally healthy from the virus, to be taken once or twice a year. , and are a great stimulus to the continuation of tests based on monoclonal antibody therapies.
